ArticleMolecules (Basel, Switzerland)2021

Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes.

Guoxia Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.